Home524372 • BOM
add
Orchid Pharma Ltd
Previous close
₹748.40
Day range
₹743.65 - ₹760.00
Year range
₹603.80 - ₹1,998.00
Market cap
38.23B INR
Avg Volume
6.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.73B | -29.25% |
Operating expense | 685.42M | -2.23% |
Net income | 149.11M | -49.20% |
Net profit margin | 8.62 | -28.23% |
Earnings per share | — | — |
EBITDA | 141.58M | -55.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.80B | 4,871.20% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 12.67B | — |
Shares outstanding | 50.72M | — |
Price to book | 2.99 | — |
Return on assets | — | — |
Return on capital | 0.96% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 149.11M | -49.20% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
871
